Symbols / WGS $75.96 -0.20%
WGS Chart
About
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 2.22B |
| Enterprise Value | 2.17B | Income | -21.02M | Sales | 427.54M |
| Book/sh | 10.54 | Cash/sh | 5.85 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1300 | IPO | — |
| P/E | — | Forward P/E | 36.95 | PEG | — |
| P/S | 5.20 | P/B | 7.21 | P/C | — |
| EV/EBITDA | 171.60 | EV/Sales | 5.08 | Quick Ratio | 2.26 |
| Current Ratio | 2.46 | Debt/Eq | 36.72 | LT Debt/Eq | — |
| EPS (ttm) | -0.73 | EPS next Y | 2.06 | EPS Growth | — |
| Revenue Growth | 26.50% | Earnings | 2026-04-28 | ROA | -1.55% |
| ROE | -7.60% | ROIC | — | Gross Margin | 69.74% |
| Oper. Margin | -10.60% | Profit Margin | -4.92% | Shs Outstand | 29.29M |
| Shs Float | 21.08M | Short Float | 23.50% | Short Ratio | 4.47 |
| Short Interest | — | 52W High | 170.87 | 52W Low | 55.17 |
| Beta | 2.15 | Avg Volume | 706.45K | Volume | 51.68K |
| Target Price | $156.67 | Recom | Strong_buy | Prev Close | $76.11 |
| Price | $75.96 | Change | -0.20% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$156.67
Mean price target
2. Current target
$76.48
Latest analyst target
3. DCF / Fair value
$23.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$76.48
Low
$130.00
High
$177.00
Mean
$156.67
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | main | Piper Sandler | Overweight → Overweight | $130 |
| 2026-02-24 | main | BTIG | Buy → Buy | $170 |
| 2026-02-09 | up | Wells Fargo | Equal-Weight → Overweight | $155 |
| 2025-12-22 | main | Canaccord Genuity | Buy → Buy | $170 |
| 2025-12-15 | main | Wells Fargo | Equal-Weight → Equal-Weight | $155 |
| 2025-12-12 | main | BTIG | Buy → Buy | $200 |
| 2025-11-04 | main | Wells Fargo | Equal-Weight → Equal-Weight | $140 |
| 2025-10-29 | main | Canaccord Genuity | Buy → Buy | $160 |
| 2025-10-29 | main | Guggenheim | Buy → Buy | $170 |
| 2025-10-29 | main | BTIG | Buy → Buy | $165 |
| 2025-10-22 | main | BTIG | Buy → Buy | $140 |
| 2025-10-20 | init | Canaccord Genuity | — → Buy | $155 |
| 2025-09-11 | main | Piper Sandler | Overweight → Overweight | $140 |
| 2025-08-04 | main | Piper Sandler | Overweight → Overweight | $120 |
| 2025-07-30 | main | Wells Fargo | Equal-Weight → Equal-Weight | $95 |
| 2025-07-09 | init | Piper Sandler | — → Overweight | $110 |
| 2025-06-30 | main | Guggenheim | Buy → Buy | $115 |
| 2025-05-09 | up | Jefferies | Hold → Buy | $80 |
| 2025-05-01 | main | TD Securities | Buy → Buy | $110 |
| 2025-05-01 | main | Wells Fargo | Equal-Weight → Equal-Weight | $78 |
News
RSS: Latest WGS news- Time To Buy The Dip In GeneDx Stock? - Trefis hu, 12 Mar 2026 13
- Farallon Capital Management LLC Sells 321,677 Shares of GeneDx Holdings Corp. $WGS - MarketBeat Mon, 16 Mar 2026 10
- Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500 Fri, 13 Mar 2026 02
- COO Share Sale Highlights GeneDx Valuation Gap And Recent Stock Pressure - simplywall.st Sat, 28 Feb 2026 08
- GeneDx Holdings Corp. (WGS) Surged Following Strong Earnings and Improved Guidance - Yahoo Finance ue, 24 Feb 2026 08
- $80,000 per child: gene tests shift kids from ER to planned care - Stock Titan Wed, 11 Mar 2026 21
- Is 10.2% Fall In GeneDx (WGS) Stock A Buying Opportunity? - Trefis hu, 12 Mar 2026 12
- GeneDx stock falls as Natera launches competing rare disease test - Investing.com hu, 12 Mar 2026 17
- GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS) - Seeking Alpha ue, 24 Feb 2026 08
- $WGS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative ue, 24 Feb 2026 08
- GeneDx Holdings Corp. $WGS Stake Lessened by Fred Alger Management LLC - MarketBeat Mon, 16 Mar 2026 10
- WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C - Yahoo Finance Wed, 11 Mar 2026 16
- GeneDx (WGS) CFO Kevin Feeley acquires 1,986 shares from issuer - Stock Titan Mon, 09 Mar 2026 07
- GeneDx stock falls after 2026 guidance disappoints investors By Investing.com - Investing.com Mon, 12 Jan 2026 08
- Portolan Capital Management LLC Has $4.75 Million Stock Holdings in GeneDx Holdings Corp. $WGS - MarketBeat Sat, 14 Mar 2026 09
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3678 | 319059.0 | — | Sale at price 86.75 per share. | STUELAND KATHERINE | Chief Executive Officer | — | 2026-03-09 00:00:00 | D |
| 1 | 1280 | 111045.0 | — | Sale at price 86.75 per share. | FEELEY KEVIN | Chief Financial Officer | — | 2026-03-09 00:00:00 | D |
| 2 | 2462 | nan | — | — | FEELEY KEVIN | Chief Financial Officer | — | 2026-03-09 00:00:00 | D |
| 3 | 6546 | nan | — | — | STUELAND KATHERINE | Chief Executive Officer | — | 2026-03-09 00:00:00 | D |
| 4 | 3404 | 299926.0 | — | Stock Award(Grant) at price 88.11 per share. | STUELAND KATHERINE | Chief Executive Officer | — | 2026-03-06 00:00:00 | D |
| 5 | 1986 | 174986.0 | — | Stock Award(Grant) at price 88.11 per share. | FEELEY KEVIN | Chief Financial Officer | — | 2026-03-06 00:00:00 | D |
| 6 | 169521 | 13460090.0 | — | Purchase at price 70.34 - 82.06 per share. | MEISTER KEITH A | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2026-03-05 00:00:00 | I |
| 7 | 25459 | 2001371.0 | — | Sale at price 77.63 - 79.25 per share. | STUELAND KATHERINE | Chief Executive Officer | — | 2026-03-04 00:00:00 | D |
| 8 | 6187 | 486370.0 | — | Sale at price 77.63 - 79.25 per share. | FEELEY KEVIN | Chief Financial Officer | — | 2026-03-04 00:00:00 | D |
| 9 | 47684 | — | — | Stock Award(Grant) at price 0.00 per share. | STUELAND KATHERINE | Chief Executive Officer | — | 2026-03-03 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -6.61K | -80.22K | -46.16K | -11.47M |
| TaxRateForCalcs | 0.01 | 0.01 | 0.01 | 0.08 |
| NormalizedEBITDA | 13.35M | 12.11M | -127.23M | -258.28M |
| TotalUnusualItems | -1.20M | -13.37M | -9.23M | -139.92M |
| TotalUnusualItemsExcludingGoodwill | -1.20M | -13.37M | -9.23M | -139.92M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -21.02M | -52.29M | -175.77M | -548.98M |
| ReconciledDepreciation | 25.22M | 21.95M | 33.73M | 59.31M |
| ReconciledCostOfRevenue | 129.37M | 111.05M | 112.56M | 261.44M |
| EBITDA | 12.15M | -1.26M | -136.46M | -398.20M |
| EBIT | -13.08M | -23.21M | -170.19M | -457.51M |
| NetInterestIncome | -2.54M | -3.03M | 1.11M | -666.00K |
| InterestExpense | 3.21M | 2.83M | ||
| InterestIncome | 2.54M | 79.00K | ||
| NormalizedIncome | -19.82M | -39.00M | -166.58M | -420.54M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -21.02M | -52.29M | -175.77M | -548.98M |
| TotalExpenses | 440.62M | 328.66M | 372.76M | 692.20M |
| TotalOperatingIncomeAsReported | -13.08M | -23.21M | -180.60M | -667.65M |
| DilutedAverageShares | 26.89M | 24.31M | 10.24M | 3.28M |
| BasicAverageShares | 26.89M | 24.31M | 10.24M | 3.28M |
| DilutedEPS | -1.94 | -7.23 | -53.79 | -74.91 |
| BasicEPS | -1.94 | -7.23 | -53.79 | -74.91 |
| DilutedNIAvailtoComStockholders | -21.02M | -52.29M | -175.77M | -548.98M |
| NetIncomeCommonStockholders | -21.02M | -52.29M | -175.77M | -548.98M |
| NetIncome | -21.02M | -52.29M | -175.77M | -548.98M |
| NetIncomeIncludingNoncontrollingInterests | -21.02M | -52.29M | -175.77M | -548.98M |
| NetIncomeContinuousOperations | -21.02M | -52.29M | -175.77M | -548.98M |
| TaxProvision | -116.00K | -343.00K | -926.00K | -49.05M |
| PretaxIncome | -21.14M | -52.63M | -176.69M | -598.03M |
| OtherIncomeExpense | -5.52M | -26.38M | -7.61M | -139.86M |
| OtherNonOperatingIncomeExpenses | -4.32M | -13.01M | 1.62M | 57.00K |
| SpecialIncomeCharges | 0.00 | 0.00 | -10.40M | -210.15M |
| WriteOff | 0.00 | 0.00 | 10.40M | 210.15M |
| GainOnSaleOfSecurity | -1.20M | -13.37M | 1.17M | 70.23M |
| NetNonOperatingInterestIncomeExpense | -2.54M | -3.03M | 1.11M | -666.00K |
| TotalOtherFinanceCost | 2.54M | 3.03M | -1.11M | 666.00K |
| InterestExpenseNonOperating | 3.21M | 2.83M | ||
| InterestIncomeNonOperating | 2.54M | 79.00K | ||
| OperatingIncome | -13.08M | -23.21M | -170.19M | -457.51M |
| OperatingExpense | 311.25M | 217.61M | 260.20M | 430.76M |
| OtherOperatingExpenses | 3.41M | 7.22M | 6.31M | 5.66M |
| ResearchAndDevelopment | 72.03M | 45.72M | 58.27M | 86.20M |
| SellingGeneralAndAdministration | 239.22M | 168.48M | 194.71M | 338.24M |
| SellingAndMarketingExpense | 88.41M | 67.37M | 60.96M | 122.08M |
| GeneralAndAdministrativeExpense | 150.82M | 101.11M | 133.75M | 216.17M |
| OtherGandA | 150.82M | 101.11M | 133.75M | 216.17M |
| GrossProfit | 298.17M | 194.40M | 90.01M | -26.75M |
| CostOfRevenue | 129.37M | 111.05M | 112.56M | 261.44M |
| TotalRevenue | 427.54M | 305.45M | 202.57M | 234.69M |
| OperatingRevenue | 416.67M | 302.16M | 195.65M | 227.33M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 29.25M | 28.02M | 25.98M | 11.77M |
| ShareIssued | 29.25M | 28.02M | 25.98M | 11.77M |
| TotalDebt | 113.17M | 116.17M | 119.27M | 77.13M |
| TangibleBookValue | 126.18M | 86.65M | 55.39M | 67.06M |
| InvestedCapital | 360.90M | 297.16M | 280.70M | 264.70M |
| WorkingCapital | 159.38M | 143.15M | 123.52M | 68.33M |
| NetTangibleAssets | 126.18M | 86.65M | 55.39M | 67.06M |
| CapitalLeaseObligations | 60.45M | 64.25M | 66.58M | 66.13M |
| CommonStockEquity | 308.18M | 245.25M | 228.02M | 253.71M |
| TotalCapitalization | 356.36M | 297.16M | 280.70M | 259.95M |
| TotalEquityGrossMinorityInterest | 308.18M | 245.25M | 228.02M | 253.71M |
| StockholdersEquity | 308.18M | 245.25M | 228.02M | 253.71M |
| GainsLossesNotAffectingRetainedEarnings | 936.00K | 830.00K | 425.00K | 0.00 |
| OtherEquityAdjustments | 936.00K | 830.00K | 425.00K | |
| RetainedEarnings | -1.37B | -1.35B | -1.30B | -1.12B |
| AdditionalPaidInCapital | 1.68B | 1.60B | 1.53B | 1.38B |
| CapitalStock | 3.00K | 2.00K | 2.00K | 1.00K |
| CommonStock | 3.00K | 2.00K | 2.00K | 1.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 215.53M | 174.13M | 190.74M | 237.24M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 106.62M | 119.32M | 131.92M | 92.94M |
| OtherNonCurrentLiabilities | 1.64M | 1.60M | 32.15M | |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| DerivativeProductLiabilities | 0.00 | 3.52M | 2.73M | 418.00K |
| EmployeeBenefits | 0.00 | |||
| NonCurrentDeferredLiabilities | 757.00K | 965.00K | 1.56M | 2.66M |
| NonCurrentDeferredTaxesLiabilities | 757.00K | 965.00K | 1.56M | 2.66M |
| LongTermDebtAndCapitalLeaseObligation | 104.22M | 112.83M | 115.63M | 66.26M |
| LongTermCapitalLeaseObligation | 56.05M | 60.92M | 62.94M | 60.01M |
| LongTermDebt | 48.18M | 51.91M | 52.69M | 6.25M |
| LongTermProvisions | 2.00M | 12.00M | 22.00M | |
| CurrentLiabilities | 108.91M | 54.82M | 58.82M | 144.30M |
| OtherCurrentLiabilities | 11.27M | 2.84M | 2.02M | 24.67M |
| CurrentDeferredLiabilities | 40.00K | 473.00K | ||
| CurrentDeferredRevenue | 40.00K | 473.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 8.95M | 3.34M | 3.65M | 10.87M |
| CurrentCapitalLeaseObligation | 4.40M | 3.34M | 3.65M | 6.12M |
| CurrentDebt | 4.54M | 1.21M | 497.00K | 4.75M |
| OtherCurrentBorrowings | 4.54M | 1.21M | 497.00K | 4.75M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 30.41M | 16.99M | 14.32M | 13.20M |
| CurrentProvisions | 10.53M | 10.59M | 15.04M | 17.00M |
| PayablesAndAccruedExpenses | 47.76M | 21.07M | 23.80M | 78.56M |
| CurrentAccruedExpenses | 44.66M | 11.50M | 12.18M | 28.95M |
| Payables | 3.10M | 9.56M | 11.62M | 49.61M |
| DuetoRelatedPartiesCurrent | 643.00K | 1.61M | 1.38M | 3.59M |
| AccountsPayable | 2.46M | 7.95M | 10.24M | 46.02M |
| TotalAssets | 523.71M | 419.38M | 418.76M | 490.94M |
| TotalNonCurrentAssets | 255.42M | 221.41M | 236.42M | 278.32M |
| OtherNonCurrentAssets | 4.32M | 4.31M | 4.41M | 7.38M |
| GoodwillAndOtherIntangibleAssets | 182.00M | 158.60M | 172.62M | 186.65M |
| OtherIntangibleAssets | 168.48M | 158.60M | 172.62M | 186.65M |
| Goodwill | 13.52M | 0.00 | ||
| NetPPE | 69.11M | 58.51M | 59.38M | 84.28M |
| AccumulatedDepreciation | -25.52M | -52.48M | -46.45M | -101.46M |
| GrossPPE | 94.62M | 110.98M | 105.83M | 185.75M |
| Leases | 14.80M | 14.65M | 14.61M | 35.56M |
| ConstructionInProgress | 7.45M | 4.96M | 3.11M | 3.39M |
| OtherProperties | 56.30M | 47.17M | 45.04M | 95.40M |
| MachineryFurnitureEquipment | 11.55M | 39.67M | 38.54M | 45.12M |
| BuildingsAndImprovements | 4.53M | 4.53M | 4.53M | 6.28M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 268.29M | 197.97M | 182.34M | 212.62M |
| OtherCurrentAssets | 1.51M | 1.08M | 1.96M | 31.68M |
| RestrictedCash | 13.47M | 0.00 | ||
| PrepaidAssets | 7.17M | 7.42M | 8.64M | 11.82M |
| Inventory | 13.95M | 10.65M | 8.78M | 13.66M |
| Receivables | 74.37M | 37.63M | 32.82M | 43.34M |
| DuefromRelatedPartiesCurrent | 203.00K | 445.00K | 708.00K | 54.00K |
| AccountsReceivable | 74.37M | 37.43M | 32.37M | 42.63M |
| CashCashEquivalentsAndShortTermInvestments | 171.28M | 141.19M | 130.15M | 123.93M |
| OtherShortTermInvestments | 66.28M | 55.97M | 30.47M | 0.00 |
| CashAndCashEquivalents | 105.00M | 85.21M | 99.68M | 123.93M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 14.26M | -33.99M | -185.86M | -333.48M |
| RepaymentOfDebt | -3.66M | -3.23M | -5.60M | -3.29M |
| IssuanceOfDebt | 0.00 | 0.00 | 48.55M | 0.00 |
| IssuanceOfCapitalStock | 46.70M | 46.50M | 143.00M | 197.66M |
| CapitalExpenditure | -19.02M | -5.49M | -5.71M | -14.32M |
| InterestPaidSupplementalData | 6.41M | 6.68M | 3.04M | 1.93M |
| IncomeTaxPaidSupplementalData | 1.27M | 1.17M | 1.47M | 1.24M |
| EndCashPosition | 105.99M | 86.20M | 100.67M | 138.30M |
| BeginningCashPosition | 86.20M | 100.67M | 138.30M | 401.47M |
| ChangesInCash | 19.79M | -14.47M | -37.63M | -263.17M |
| FinancingCashFlow | 48.02M | 44.16M | 186.24M | 197.31M |
| CashFlowFromContinuingFinancingActivities | 48.02M | 44.16M | 186.24M | 197.31M |
| NetOtherFinancingCharges | 197.66M | 63.24M | ||
| ProceedsFromStockOptionExercised | 4.98M | 891.00K | 285.00K | 2.95M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | 46.70M | 46.50M | 143.00M | 197.66M |
| CommonStockIssuance | 46.70M | 46.50M | 143.00M | 197.66M |
| NetIssuancePaymentsOfDebt | -3.66M | -3.23M | 42.95M | -3.29M |
| NetLongTermDebtIssuance | -3.66M | -3.23M | 42.95M | -3.29M |
| LongTermDebtPayments | -3.66M | -3.23M | -5.60M | -3.29M |
| LongTermDebtIssuance | 0.00 | 0.00 | 48.55M | 0.00 |
| InvestingCashFlow | -61.52M | -30.13M | -43.73M | -141.33M |
| CashFlowFromContinuingInvestingActivities | -61.52M | -30.13M | -43.73M | -141.33M |
| NetOtherInvestingChanges | -8.11M | |||
| NetInvestmentPurchaseAndSale | -9.64M | -24.64M | -29.91M | 0.00 |
| SaleOfInvestment | 46.03M | 41.66M | 17.77M | 0.00 |
| PurchaseOfInvestment | -55.68M | -66.30M | -47.67M | 0.00 |
| NetBusinessPurchaseAndSale | -32.86M | 0.00 | -12.14M | -127.00M |
| PurchaseOfBusiness | -32.86M | 0.00 | -12.14M | -127.00M |
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | -461.00K | -7.17M |
| PurchaseOfIntangibles | 0.00 | 0.00 | -461.00K | -7.17M |
| NetPPEPurchaseAndSale | -19.02M | -5.49M | -5.25M | -7.16M |
| PurchaseOfPPE | -19.02M | -5.49M | -5.25M | -7.16M |
| OperatingCashFlow | 33.28M | -28.50M | -180.15M | -319.15M |
| CashFlowFromContinuingOperatingActivities | 33.28M | -28.50M | -180.15M | -319.15M |
| ChangeInWorkingCapital | -15.60M | -24.75M | -38.24M | 33.88M |
| ChangeInOtherWorkingCapital | 11.97M | 3.72M | -2.53M | -8.46M |
| ChangeInOtherCurrentLiabilities | -19.47M | 3.24M | ||
| ChangeInOtherCurrentAssets | -2.00K | -1.86M | ||
| ChangeInPayablesAndAccruedExpense | 12.10M | -20.46M | -46.95M | 34.46M |
| ChangeInPrepaidAssets | 11.13M | -14.25M | ||
| ChangeInInventory | -3.44M | -2.58M | 975.00K | 2.35M |
| ChangeInReceivables | -36.23M | -5.42M | 10.26M | 5.53M |
| ChangesInAccountReceivables | -36.23M | -5.42M | 10.26M | 5.53M |
| OtherNonCashItems | 12.38M | 4.24M | -7.34M | 2.74M |
| StockBasedCompensation | 32.16M | 9.14M | -326.00K | 41.98M |
| ProvisionandWriteOffofAssets | 135.00K | 180.00K | 3.91M | 1.12M |
| AssetImpairmentCharge | 0.00 | 0.00 | 10.40M | 210.15M |
| DeferredTax | -343.00K | -926.00K | -49.12M | 0.00 |
| DeferredIncomeTax | -343.00K | -926.00K | -49.12M | 0.00 |
| DepreciationAmortizationDepletion | 25.22M | 21.95M | 33.73M | 59.31M |
| DepreciationAndAmortization | 25.22M | 21.95M | 33.73M | 59.31M |
| OperatingGainsLosses | 13.37M | -5.60M | -70.23M | -198.10M |
| GainLossOnInvestmentSecurities | 13.37M | -1.17M | -70.23M | -198.40M |
| NetIncomeFromContinuingOperations | -21.02M | -52.29M | -175.77M | -548.98M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for WGS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|